Faron Pharmaceuticals Oy (FARN) — Net Asset Momentum

Latest YoY growth as of December 2024: +35.6%

Faron Pharmaceuticals Oy (FARN) recorded a net asset momentum of 35.6% as of December 2024, with net assets of GBX-9.76 Million GBX. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Faron Pharmaceuticals Oy (FARN) defensive interval to measure how many days the company can operate on defensive assets alone.

YoY Momentum

+35.6%
Year-over-year

Current Net Assets

GBX-9.76 Million
GBX · December 2024

Years of Data

13
2012 – 2024

Country

UK
LSE

Faron Pharmaceuticals Oy Net Asset Momentum (2012–2024)

This chart tracks Faron Pharmaceuticals Oy's year-over-year net asset growth across 13 annual reporting periods from 2012 to 2024. The most recent momentum reading is +35.6%, with net assets of GBX-9.76 Million GBX as of December 2024. Read FARN current and long-term liabilities for a breakdown of total debt and financial obligations.

Annual Net Asset History for Faron Pharmaceuticals Oy (2012–2024)

The table below shows the complete annual net asset history for Faron Pharmaceuticals Oy from 2012 to 2024, covering 13 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Faron Pharmaceuticals Oy (FARN) market capitalisation.

Year Net Assets (GBX) Total Assets Total Liabilities YoY Momentum
2024 GBX-9.76 Million GBX12.52 Million GBX22.28 Million ▲ +35.6%
2023 GBX-15.16 Million GBX10.22 Million GBX25.38 Million ▼ -32.1%
2022 GBX-11.48 Million GBX11.27 Million GBX22.75 Million ▼ -493.3%
2021 GBX2.92 Million GBX13.18 Million GBX10.26 Million ▲ +257.8%
2020 GBX-1.85 Million GBX8.37 Million GBX10.22 Million ▼ -214.8%
2019 GBX1.61 Million GBX10.21 Million GBX8.60 Million ▲ +336.3%
2018 GBX369.00K GBX8.00 Million GBX7.63 Million ▼ -92.2%
2017 GBX4.74 Million GBX14.89 Million GBX10.14 Million ▼ -56.4%
2016 GBX10.88 Million GBX17.29 Million GBX6.40 Million ▼ -2.6%
2015 GBX11.18 Million GBX14.82 Million GBX3.64 Million ▲ +1040.9%
2014 GBX-1.19 Million GBX2.17 Million GBX3.35 Million ▼ -25.2%
2013 GBX-949.00K GBX2.24 Million GBX3.19 Million ▼ -13.4%
2012 GBX-837.00K GBX1.94 Million GBX2.77 Million